Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: The Coronary Artery Calcification in Type 1 Diabetes Study

Journal of Clinical Lipidology

Volumn 8, Issue 6, 2014, Pages 576-583

  Bjornstad, Petter ^a   Maahs, David M ^a,b   Wadwa, R Paul ^a,b   Pyle, Laura ^a,b   Rewers, Marian ^a,b   Eckel, Robert H ^b   Snell Bergeon, Janet K ^a,b  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Dyslipidemia; Integrated discrimination index; Macrovascular complications; Microvascular complications; Net reclassification improvement; Triglycerides; Type 1 diabetes

Indexed keywords

ALBUMIN; APOLIPOPROTEIN B; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; APOLIPOPROTEIN; CHOLESTEROL;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ELECTRON BEAM TOMOGRAPHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CALCINOSIS; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY BLOOD VESSEL; FOLLOW UP; INCIDENCE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; YOUNG ADULT;

ADULT; ALBUMINURIA; APOLIPOPROTEINS; CALCINOSIS; CHOLESTEROL; CORONARY VESSELS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES; YOUNG ADULT;

EID: 84919457779     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2014.08.008     Document Type: Article

References (35)

1. A.J. Collins, R.N. Foley, C. Herzog, and et al. Us renal data system 2010 annual data report Am J Kidney Dis 57 1 Suppl 1 2011 A8 e1-526
2. P. Libby, D.M. Nathan, K. Abraham, and et al. Report of the national heart, lung, and blood institute-national institute of diabetes and digestive and kidney diseases working group on cardiovascular complications of type 1 diabetes mellitus Circulation 111 25 2005 3489 3493
3. H.C. Chen, J.Y. Guh, J.M. Chang, and et al. Role of lipid control in diabetic nephropathy Kidney Int Suppl 94 2005 S60 S62
4. D.M. Maahs, D. Jalal, M. Chonchol, and et al. Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: The cacti study Diabetes Care 36 9 2013 2607 2614
5. G.P. Forlenza, and M. Rewers The epidemic of type 1 diabetes: What is it telling us? Curr Opin Endocrinol Diabetes Obes 18 4 2011 248 251
6. G. Pambianco, T. Costacou, D. Ellis, and et al. The 30-year natural history of type 1 diabetes complications: The pittsburgh epidemiology of diabetes complications study experience Diabetes 55 5 2006 1463 1469
7. A.J. Jenkins, T.J. Lyons, D. Zheng, and et al. Lipoproteins in the dcct/edic cohort: Associations with diabetic nephropathy Kidney Int 64 3 2003 817 828
8. M. Miller, N.J. Stone, C. Ballantyne, and et al. Triglycerides and cardiovascular disease: A scientific statement from the american heart association Circulation 123 20 2011 2292 2333
9. P.M. Kearney, L. Blackwell, R. Collins, and et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis Lancet 371 9607 2008 117 125
10. Standards of medical care in diabetes-2014 Diabetes Care 37 Suppl 1 2014 S14 80
11. D. Dabelea, G. Kinney, J.K. Snell-Bergeon, and et al. Effect of type 1 diabetes on the gender difference in coronary artery calcification: A role for insulin resistance? The coronary artery calcification in type 1 diabetes (cacti) study Diabetes 52 11 2003 2833 2839
12. P.M. Ridker, N. Rifai, N.R. Cook, and et al. Non-hdl cholesterol, apolipoproteins a-i and b100, standard lipid measures, lipid ratios, and crp as risk factors for cardiovascular disease in women JAMA 294 3 2005 326 333
13. J.C. Rutledge, K.F. Ng, H.H. Aung, and et al. Role of triglyceride-rich lipoproteins in diabetic nephropathy Nat Rev Nephrol 6 6 2010 361 370
14. D.M. Maahs, G.L. Kinney, P. Wadwa, and et al. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population Diabetes Care 28 2 2005 301 306
15. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and et al. Evaluating the added predictive ability of a new marker: From area under the roc curve to reclassification and beyond Stat Med 27 2 2008 157 172 discussion 207-12
16. M.J. Pencina, R.B. D'Agostino, K.M. Pencina, and et al. Interpreting incremental value of markers added to risk prediction models Am J Epidemiol 176 6 2012 473 481
17. M.J. Leening, M.M. Vedder, J.C. Witteman, and et al. Net reclassification improvement: Computation, interpretation, and controversies: A literature review and clinician's guide Ann Intern Med 160 2 2014 122 131
18. C.S. Fox, P. Gona, M.G. Larson, and et al. A multi-marker approach to predict incident ckd and microalbuminuria J Am Soc Nephrol 21 12 2010 2143 2149
19. M.J. Budoff, K.L. Lane, H. Bakhsheshi, and et al. Rates of progression of coronary calcium by electron beam tomography Am J Cardiol 86 1 2000 8 11
20. J.W. McEvoy Coronary artery calcium score and cardiovascular event prediction JAMA 304 7 2010 741 742 author reply 2
21. J.W. McEvoy, M.J. Blaha, A.P. Defilippis, and et al. Coronary artery calcium progression: An important clinical measurement? A review of published reports J Am Coll Cardiol 56 20 2010 1613 1622
22. B.R. Hemmelgarn, B.J. Manns, A. Lloyd, and et al. Relation between kidney function, proteinuria, and adverse outcomes JAMA 303 5 2010 423 429
23. K.O. Schwab, J. Doerfer, W. Hecker, and et al. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: Cross-sectional data from the german diabetes documentation and quality management system (dpv) Diabetes Care 29 2 2006 218 225
24. R.P. Wadwa, G.L. Kinney, D.M. Maahs, and et al. Awareness and treatment of dyslipidemia in young adults with type 1 diabetes Diabetes Care 28 5 2005 1051 1056
25. D.M. Maahs, J.E. Hokanson, H. Wang, and et al. Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance Diabetes 59 7 2010 1771 1779
26. A.C. Feitosa, G.S. Feitosa-Filho, F.R. Freitas, and et al. Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment Lipids Health Dis 12 2013 15
27. A.S. Gami, B.J. Witt, D.E. Howard, and et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies J Am Coll Cardiol 49 4 2007 403 414
28. H.M. Lakka, D.E. Laaksonen, T.A. Lakka, and et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 21 2002 2709 2716
29. F.L. Dunn Hyperlipidemia in diabetes mellitus Diabetes Metab Rev 6 1 1990 47 61
30. V. Tsimihodimos, I. Gazi, C. Kostara, and et al. Plasma lipoproteins and triacylglycerol are predictors of small, dense ldl particles Lipids 42 5 2007 403 409
31. T.M. Davis, R. Ting, J.D. Best, and et al. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: The fenofibrate intervention and event lowering in diabetes (field) study Diabetologia 54 2 2011 280 290
32. R. Scott, R. O'Brien, G. Fulcher, and et al. Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: The fenofibrate intervention and event lowering in diabetes (field) study Diabetes Care 32 3 2009 493 498
33. H.N. Ginsberg The accord (action to control cardiovascular risk in diabetes) lipid trial: What we learn from subgroup analyses Diabetes Care 34 Suppl 2 2011 S107 S108
34. L.J. Shaw, P. Raggi, E. Schisterman, and et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality Radiology 228 3 2003 826 833
35. S. Stark Casagrande, J.E. Fradkin, S.H. Saydah, and et al. The prevalence of meeting a1c, blood pressure, and ldl goals among people with diabetes, 1988-2010 Diabetes Care 36 8 2013 2271 2279